News

After getting the CE marking, Spineart is proud to announce that we received the FDA 510(k) clearance for the new Minimal Invasive Thoracolumbar Posterior Fixation System, PERLA® TL MIS on January 15^th, 2021.

PERLA® TL MIS is a comprehensive system including polyaxial screws with Extended Tabs which enable a connection to different rod diameters. It contributes to the treatment of spinal pathologies through Percutaneous and Minimal Invasive Surgeries and perfectly complements the new PERLA® TL solutions designed for the treatment of degenerative pathologies.

Further extensions of the PERLA® TL solution are expected to come.

After getting the CE marking, Spineart is proud to announce that we received the FDA 510(k) clearance for the new Minimal Invasive Thoracolumbar Posterior Fixation System, PERLA® TL MIS on January 15^th, 2021.

PERLA® TL MIS is a comprehensive system including polyaxial screws with Extended Tabs which enable a connection to different rod diameters. It contributes to the treatment of spinal pathologies through Percutaneous and Minimal Invasive Surgeries and perfectly complements the new PERLA® TL solutions designed for the treatment of degenerative pathologies.

Further extensions of the PERLA® TL solution are expected to come.

On January 11th 2021, Dr Juan M Valdivia Valdivia MD., FAANS. neurosurgeon, successfully performed the first worldwide procedure with PERLA® in Tampa, FL, United States of America. 

The PERLA® system allows to fuse from occiput to thoracic spine. After the procedure, a fusion from Occiput to C4, Dr. Valdivia noted that, „the Perla Occipital Plate is a user friendly system. The angle instrumentation was particularly useful to the success of the procedure”. 

The PERLA® posterior occipito-cervico-thoracic fixation system is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the cranio-cervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1 to T3). 

The 20th annual meeting of the Swiss Society of Spinal Surgery was held virtually this year.

During the congress, surgeons were able to watch live surgery performed by PD. DR. Gianluca Maestretti using our New Secured Lumbar Anterior Cage, SCARLET® AL-T.

The implant was developed using the company’s flagship 3D printed Ti- LIFE Technology, a titanium bone-like structure that supports bone cell adhesion and encourages bone ingrowth. A number of design features make SCARLET® AL-T unique: the cages feature internal tubes that help to prevent screw misalignment, the screws are designed with a triple lead screw thread and sharp threaded end-tip eliminating the need to drill or awl, and the screw anti-backout system provides both tactile and visual feedback.

More information about this product on: https://www.spineart.com/products/scarlet-al-t/

Spineart is pleased to announce the first worldwide surgery of TEKTONA®2, the new Vertebral Fragment Reduction System.  

On January 4th 2021, Dr Slawomir Moszko, neurosurgeon and vice chief of the Department of Neurosurgery, Spine Surgery and Interventional Neuroradiology successfully performed the procedure in the DonauIsar-Klinikum, Deggendorf, Germany.  

The TEKTONA®2 system is a vertebral fragment reduction instrument designed to assist in the reduction of vertebral body fractures using a percutaneous surgical approach. 

Spineart is pleased to announce the first implantation of the Lateral Ti-LIFE cage JULIET®Ti LL in Australia.

Dr Ivan Bhaskar, neurosurgeon, successfully performed the procedure in St Vincent Hospital in Melbourne on November 20^th, 2020.

JULIET®Ti LL is a Lateral cage featuring Ti-LIFE Technology, a structure that mimics the geometry of trabecular bone and is designed to promote bone in-growth. JULIET®Ti LL features an overall reduction in material density, that optimizes medical imaging when making postoperative evaluations.